China NMPA Drug Inspection - Shandong Bausch & Lomb Freda Pharmaceutical Co., Ltd. - Levofloxacin Hydrochloride Eye Drops
China NMPA drug inspection for Shandong Bausch & Lomb Freda Pharmaceutical Co., Ltd. published August 17, 2018. Drug: Levofloxacin Hydrochloride Eye Drops. The Ningxia Drug Sampling Inspection Information Announcement (No. 09, 2018), published on August 17, 2018, reports on r
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA drug inspection for Shandong Bausch & Lomb Freda Pharmaceutical Co., Ltd. published August 17, 2018. Drug: Levofloxacin Hydrochloride Eye Drops. The Ningxia Drug Sampling Inspection Information Announcement (No. 09, 2018), published on August 17, 2018, reports on r
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox